ISRCTN ISRCTN08609907
DOI https://doi.org/10.1186/ISRCTN08609907
Secondary identifying numbers 6659
Submission date
07/07/2010
Registration date
07/07/2010
Last edited
05/12/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Lois Thomas
Scientific

Room 434, Brook Building
University of Central Lancashire
Preston
PR1 2HE
United Kingdom

Email lhthomas@uclan.ac.uk

Study information

Study designMulticentre randomised interventional diagnosis, process of care and treatment trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleManagement of urinary incontinence for patients recovering from stroke: a multicentre randomised interventional trial
Study acronymICONS
Study objectivesUrinary incontinence is common after stroke and can be very unpleasant and a cause of distress and embarrassment for patients and their carers. Urinary incontinence may hamper rehabilitation and may affect whether or not patients are able to return to their own home, as well as return to leisure activities, work or an active social life. It is also costly for families and for the Health Service. We would like to try out a package of assessment and treatment of urinary incontinence while people are in hospital, which is designed to help them become continent again.
Ethics approval(s)Bradford Research Ethics Committee pending approval as of 20th July 2010 (ref: 10/H1302/60)
Health condition(s) or problem(s) studiedTopic: Stroke Research Network; Subtopic: Rehabilitation; Disease: Therapy type, In hospital study
Intervention1. Systematic voiding programme (intervention group I):
This group will receive the individualised systematic voiding programme tailored to the physical and cognitive capabilities of each patient. The programme has two routes:
1.1. A combined package including bladder training and pelvic floor muscle training for those patients who are cognitively able
1.2. Prompted voiding for those with cognitive impairment

2. Systematic voiding programme PLUS supported implementation (intervention group II):
This group will receive the intervention outlined above, together with supported implementation. This will comprise:
2.1. Identification of barriers and facilitators to the intervention
2.2. Targeted organisational development activities
2.3. Use of facilitation as a means of supporting change

3. Usual care (control group):
Participants in this group will receive usual care provided by the stroke service. This may comprise:
3.1. Checking for urinary tract infection
3.2. Checking for overflow incontinence (bladder scanners will be provided)
3.3. Containment using a variety of devices (for example absorbent products) with regular changes and some form of toileting schedule

Total duration of treatment: participants will receive the interventions for the duration of their stay in the acute/rehabilitation stroke units. The intervention phase of the trial will last for nine months.
Total duration of follow up: 12 months post-stroke
Intervention typeOther
Primary outcome measurePresence/absence of incontinence at six weeks post-stroke
Secondary outcome measuresQuality of life: Incontinence Quality of Life Instrument (I-QOL), measured at 6 weeks, 3 months and (for participants recruited in the first three months only) 12 months.
Overall study start date01/01/2010
Completion date30/06/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned sample size: 796; UK sample size: 796
Key inclusion criteria1. Aged 18 or over, either sex
2. Diagnosis of stroke based on the World Health Organization (WHO) criteria
3. Urinary incontinence (UI) as defined by the International Continence Society as "involuntary loss of urine"
4. Incontinence classified as stress UI, urge UI, mixed UI or 'functional' UI OR to be catheterised in the acute phase
5. Conscious (defined as either 'alert' or 'drowsy' on the Clinical Status on Admission Item of the European Stroke Database)
6. Medically stable as judged by the clinical team
Key exclusion criteriaPatients who refuse consent
Date of first enrolment01/01/2010
Date of final enrolment30/06/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Room 434, Brook Building
Preston
PR1 2HE
United Kingdom

Sponsor information

Lancashire Teaching Hospitals NHS Trust (UK)
Hospital/treatment centre

Royal Preston Hospital
Sharoe Green Lane
Fulwood
Preston
PR2 9HT
England
United Kingdom

Email douglas.mitchell@lthtr.nhs.uk
Website http://www.lancsteachinghospitals.nhs.uk/
ROR logo "ROR" https://ror.org/02j7n9748

Funders

Funder type

Government

National Institute for Health Research (NIHR) (UK) - Programme Grant for Applied Research (PGfAR)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 20/05/2011 Yes No
Results article feasibility trial results 23/12/2014 Yes No
Results article results 21/08/2015 Yes No

Editorial Notes

05/12/2017: internal review.